Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05164705 · ClinicalTrials.gov registry record · NA
Improving Human Cerebrovascular Function Using Acute Intermittent Hypoxia
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT05164705 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 33 participants.
The verdict
NCT05164705, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This study uses magnetic resonance imaging to determine whether 3 weeks of repeated exposure to Acute Intermittent Hypoxia can improve brain blood flow or blood flow regulation in healthy adults.
Interventions
- OTHER Acute Intermittent Hypoxia
- OTHER Sham Acute Intermittent Hypoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2022-05-03 |
| Est. Completion | 2024-04-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05164705
The ClinicalTrials.gov registry entry for NCT05164705 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acute Intermittent Hypoxia is the first listed.
NCT05164705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05164705 about?
NCT05164705 is a clinical study titled "Improving Human Cerebrovascular Function Using Acute Intermittent Hypoxia". This study uses magnetic resonance imaging to determine whether 3 weeks of repeated exposure to Acute Intermittent Hypoxia can improve brain blood flow or blood flow regulation in healthy adults.
What is the current status of trial NCT05164705?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2022-05-03. Estimated completion is 2024-04-05.
What interventions are being tested in trial NCT05164705?
The interventions under investigation include: Acute Intermittent Hypoxia (OTHER), Sham Acute Intermittent Hypoxia (OTHER).
Who is sponsoring clinical trial NCT05164705?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.